A partial differential equation model and its reduction to an ordinary differential equation model for prostate tumor growth under intermittent hormone therapy

Journal of Mathematical Biology

Volumn 69, Issue 4, 2014, Pages 817-838

  Tao, Youshan ^a   Guo, Qian ^b   Aihara, Kazuyuki ^c  

^a DONGHUA UNIVERSITY   (China)

^b SHANGHAI NORMAL UNIVERSITY   (China)

^c INSTITUTE OF INDUSTRIAL SCIENCE   (Japan)

Author keywords

Androgen independence; Free boundary problem; Hybrid system; Intermittent androgen suppression; Partial differential equations; Prostate cancer

Indexed keywords

EID: 84882518867     PISSN: 03036812     EISSN: 14321416     Source Type: Journal    
DOI: 10.1007/s00285-013-0718-y     Document Type: Article

References (30)

1. Abrahamsson PA (2010) Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur Urol 57:49–59
2. Adam JA (1996) A simplified mathematical model of tumor growth. Math Biosci 81:224–229
3. Akakura K, Bruchovsky N, Goldenbeg SL, Rennie PS, Buckley AR, Sullivan LD (1993) Effects of intermittent androgen suppression on androgen-dependent tumors: apoptosis and serum prostate-specific antigen. Cancer 71:2782–2790
4. Bellomo N, Li NK, Maini PK (2008) On the foundations of cancer modelling: selected topics, speculations and perspective. Math Mod Meth Appl Sci 18:593–646
5. Bladou F, Vessella RL, Buhler KR, Ells WJ, True LD, Lange PH (1996) Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration. Int. J. Cancer 7:785–790
6. Bruchovsky N, Rennie PS, Coldman AJ, Goldenberg SL, To M, Lawson D (1990) Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. Cancer Res 50:2275–2282
7. Bruchovsky N, Klotz LH, Sadar M, Crook JM, Hoffart D, Godwin L, Warkentin M, Gleave ME, Goldenberg SL (2000) Intermittent androgen suppression for prostate cancer: Canadian prospective trial and related observations. Mol Urol 4:191–199
8. Bruchovsky N, Klotz L, Crook J, Malone S, Ludgte C, Morris WJ, Gleave ME, Goldenberg SL (2006) Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer: clinical parameters. Cancer 107:389–395
9. Bruchovsky N, Klotz L, Crook J, Larry S, Goldenberg SL (2007) Locally advanced prostate cancer – biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy. Cancer 109:858–867
10. Byrne HM, Alarcon T, Owen MR, Webb SD, Maini PK (2006) Modelling aspects of cancer dynamics: a review. Phil Trans R Soc Lond Ser A Math Phys Eng Sci 36:1563–1578
11. Feldman BJ, Feldman D (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1:34–45
12. Friedman A (2007) Mathematical analysis and challenges arising from models of tumor growth. Math Mod Meth Appl Sci 17:1751–1772
13. Friedman A, Hu B (2006) Bifurcation from stability to instability for a free boundary problem arising in a tumor model. Arch Ration Mech Anal 180:293–330
14. Friedman A, Tao Y (2003) Analysis of a model of a virus that replicates selectively in tumor cells. J Math Biol 47:391–423
15. Greenspan H (1972) Models for the growth of a solid tumor by diffusion. Stud Appl Math 52:317–340
16. Guo Q, Tao Y, Aihara K (2008) Mathematical modeling of prostate tumor growth under intermittent androgen suppression with partial differential equations. Int J Bifurcat Chaos 18:3789–3797
17. Hirata Y, Bruchovsky N, Aihara K (2010a) Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer. J Theor Biol 264:517–527
18. Hirata Y, di Bernardo M, Bruchovsky N, Aihara K (2010b) Hybrid optimal scheduling for intermittent androgen suppression of prostate cancer. Chaos 20:045125
19. Ideta AM, Tanaka G, Takeuchi T, Aihara K (2008) A mathematical model of intermittent androgen suppression for prostate cancer. J Nonlinear Sci 18:593–614
20. Jackson TL (2004a) A mathematical model of prostate tumor growth and androgen-independent relapse. Discrete Contin Dyn Syst B 4:187–201
21. Jackson TL (2004b) A mathematical investigation of multiple pathways to recurrent prostate cancer: comparsion with experiment data. Neoplasia 6:697–704
22. Rennie PS, Bruchovsky N, Coldman AJ (1990) Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genes. J Steroid Biochem Mol Biol 37:843–847
23. Rennie P, Read J, Murphy L (2005) Hormones and Cancer. In: Tannock IF, Hill RP, Bristow RG, Harrington L (eds) The basic science of oncology. McGraw-Hill, New York, pp 400–430
24. Suzuki T, Bruchovsky N, Aihara K (2010) Piecewise affine systems modelling for optimizing hormone therapy of prostate cancer. Phil Trans R Soc A 368:5045–5059
25. Tanaka G, Hirata Y, Goldenberg SL, Bruchovsky N, Aihara K (2010a) Mathematical modelling of prostate cancer growth and its application to hormone therapy. Phil Trans R Soc 368:5029–5044
26. Tao Y, Chen M (2006) An elliptic-hyperbolic free boundary problem modelling cancer therapy. Nonlinearity 19:419–440
27. Tao Y, Guo Q, Aihara K (2009) A model at the macroscopic scale of prostate tumor growth under intermittent androgen suppression. Math Mod Meth Appl Sci 19:2177–2201
28. Tao Y, Guo Q, Aihara K (2010b) A mathematical model of prostate tumor growth under hormone therapy with mutation inhibitor. J Nonlinear Sci 20:219–240
29. Tello JI (2013) On a mathematical model of tumor growth based on cancer stem cells. Math Biosci Eng 10:263–278
30. Ward JP, King JR (2003) Mathematical modelling of drug transport in tumour multicell spheroids and monolayer cultures. Math Biosci 181:177–207